chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hives or something at the bottom of neck; hives or something at upper chest; itchy at the bottom of neck; itchy at upper chest; all red at the bottom of neck; all red at upper chest; arm was really sore - stayed home today; fatigued - took a 3 hour nap; a little bit fast heart beat - stressed about getting the vaccine; warmth through my face; This spontaneous case was reported by a consumer and describes the occurrence of STRESS (a little bit fast heart beat - stressed about getting the vaccine), FEELING HOT (warmth through my face), URTICARIA (hives or something at the bottom of neck), URTICARIA (hives or something at upper chest) and PRURITUS (itchy at the bottom of neck) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced STRESS (a little bit fast heart beat - stressed about getting the vaccine), FEELING HOT (warmth through my face), VACCINATION SITE PAIN (arm was really sore - stayed home today) and FATIGUE (fatigued - took a 3 hour nap). On 19-Mar-2021, the patient experienced URTICARIA (hives or something at the bottom of neck), URTICARIA (hives or something at upper chest), PRURITUS (itchy at the bottom of neck), PRURITUS (itchy at upper chest), ERYTHEMA (all red at the bottom of neck) and ERYTHEMA (all red at upper chest). On 19-Mar-2021, STRESS (a little bit fast heart beat - stressed about getting the vaccine) and FEELING HOT (warmth through my face) had resolved. At the time of the report, URTICARIA (hives or something at the bottom of neck), URTICARIA (hives or something at upper chest), PRURITUS (itchy at the bottom of neck), PRURITUS (itchy at upper chest), ERYTHEMA (all red at the bottom of neck), ERYTHEMA (all red at upper chest), VACCINATION SITE PAIN (arm was really sore - stayed home today) and FATIGUE (fatigued - took a 3 hour nap) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information provided.  No concomitant medication provided by Reporter.
It started with a sore arm. My left eye hurt to close and skin felt like pins and needlesThen headache. Chills, fever, then got really hot. Throwing up body aches.  I currently have a pounding head ache stomach hurts and my neck and head hurt.
ACHING ALL OVER STARTING THE MORNING; STRANGE FEELING IN BOTH THE RIGHT AND LEFT LEGS (DESCRIBED AS LITTLE POPPING THROUGHOUT WHOLE LEGS LIKE BLOOD FLOW IS POPPING AND ALSO DESCRIBED THE FEELING AS GURGLING BLOOD FLOW. THE SENSATION IS OCCURRING IN BOTH LEGS BUT MOSTLY THE RIGHT LEG); FELT LIKE SHE WAS RUN OVER BY A BUS; LEG PAIN/ LEG IS SORE ON THE BACK OF CALF; SWELLING; SMALL AMOUNT OF PAIN BEHIND THE KNEE; This spontaneous report received from a patient concerned a 57 year old female. The patient's height, and weight were not reported. The patient's past medical history included: ex-smoker, and concurrent conditions included: crooked spine, osteoarthritis, medical tape allergy, alcohol user, and platelets are large, and other pre-existing medical conditions included: patient had no drug abuse or illicit drug usage and has normal number of blood platelets. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1816027, and batch number: 1816027 expiry: 29-SEP-2021) dose was not reported, administered on 14-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On SEP-2021, the patient experienced swelling. On SEP-2021, the patient experienced small amount of pain behind the knee. On 15-SEP-2021, the patient experienced aching all over starting the morning. On 15-SEP-2021, the patient experienced strange feeling in both the right and left legs (described as little popping throughout whole legs like blood flow is popping and also described the feeling as gurgling blood flow. the sensation is occurring in both legs but mostly the right leg). On 15-SEP-2021, the patient experienced felt like she was run over by a bus. On 15-SEP-2021, the patient experienced leg pain/ leg is sore on the back of calf. Treatment medications (dates unspecified) included: curcumin. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from aching all over starting the morning, strange feeling in both the right and left legs (described as little popping throughout whole legs like blood flow is popping and also described the feeling as gurgling blood flow. the sensation is occurring in both legs but mostly the right leg), leg pain/ leg is sore on the back of calf, and felt like she was run over by a bus, and the outcome of small amount of pain behind the knee and swelling was not reported. This report was non-serious. This case, from the same reporter is linked to 20210928799, 20210928678 and 20210929077.
Shortly after receiving the vaccine, patient fainted while sitting in a chair during the 15 minute observation period.  He slowly slid off of the chair and landed beneath the chair.  EMS was immediately alerted and I went to his aid.  He quickly came to and was responsive.  EMS arrived and evaluated him and he was released with family members about one-half hour after the event.
I woke up at 2AM after receiving the vaccine earlier that day with chills, body aches, fatigue, and a very fast beating heart. I woke up initially because my heart was beating incredibly fast and it jolted me awake. These symptoms only seemed to last for a few hours and then dissipated, but I remained fatigued with slight body aches the next day.
No Adverse reactions as of now but Patient is not 18 years old yet. Patient is only 17 years and 11 months old when received the shot.
Eye pain, blurry vision, extreme light sensitivity, shaking. Treated with ibuprofen. Resolved within 12 hours.
15-30 minutes of serious threat of fainting, perspiration then shivering.  Had to get to the floor several times.  Got through the worst of it after, maybe 30 minutes, but felt unsteady & weak for approx. 4+ hours.    Also, experienced extreme sensitivity to cold water/ice on upper left side of teeth.  No treatment, yet.  I think I've recovered, but only time will tell.
Low grade fever to 100.7 degrees F; fatigue, headache, pain at injection site
Information has been received from a pharmacist referring to a 24 year old female patient. No pertinent medical history conditions were reported. On 11-AUG-2015 the patient was vaccinated with (Oka/Merck) VARIVAX (lot # L008271, expiration date 11-MAR-2017, strength, dose and route unknown). There was no concomitant medication reported. After vaccination, the patient immediately experienced left arm swelling and redness from the injection site to her elbow. The patient did not seek medical attention and no lab test was performed to the patient. The reaction lasted about 2-3 weeks. Causality between the events and (Oka/Merck) VARIVAX was not reported. Additional information has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30-year-old female patient received BNT162b2 (BNT162B2), in Mar2021 as dose 1, single (Batch/Lot number: unknown), in Apr2021 as dose 2, single (Batch/Lot number: unknown), in Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) and in Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 30 years for covid-19 immunisation. The patient's relevant medical history included: "Type 1 diabetes" (unspecified if ongoing), notes: Type 1 diabetes; "hypothyroid" (unspecified if ongoing), notes: hypothyroid. Concomitant medication(s) included: NOVOLOG; LEVOTHYROXINE; WELLBUTRIN; FLUOXETINE. The following information was reported: DRUG INEFFECTIVE (hospitalization, medically significant), SUSPECTED COVID-19 (hospitalization, medically significant) all with onset 2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient was hospitalized for drug ineffective, suspected covid-19 (hospitalization duration: 1 day(s)). Therapeutic measures were taken as a result of drug ineffective, suspected covid-19. Clinical course: Finished Paxlovid five days after COVID diagnosis; felt better the following couple of days. Then out of nowhere, I got nauseous and started throwing up for about two hours. I had to go to the hospital to get IV fluids and anti nausea meds, and the 3-4 days since getting home I have had bad cold symptoms: cough, sneezing, congestion, runny nose, fatigue. Treatment includes pepcid and anti-nausea meds and fluids.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Caller states he received his first Moderna vaccine yesterday.  Awoke today with purple veins extending down arm and across chest.  No fever, shortness of breath, cough or swelling, denies pain.  Encouraged caller to seek medical care at an Urgent Care Center or ED for evaluation.
A red, swollen rash had develop at site of injection on left arm. It is about 3 inches in diameter and has not gone away after a week.
Pt in post observation after receiving his 2nd dose of Pfizer. Pt speaking and receiving education with RN when became pale, diaphoretic, and reported feeling light headed. Pt began to posture slightly but was still speaking in complete sentences and denied any troubles breathing. Medics called. Pt reported not having eaten much today and was given a juice box prior to medics arrival. Medics arrived on scene and BG was 61 per medics. Pt given oral glucose by medics are reported feeling better. Pt ambulated out of facility with steady gait. Pt color returned and was cleared by medics to drive himself home. Pt VSS prior to leaving facility.  Initial VS: BP 100/55 Hr 55 O2 sat 100% on RA Last vitals: BP 130/90 Hr 68 O2 sat 98% on RA.
PATIENT REPORTS T-SHAPED, HARD, BLUE, SORE SPOT ON LEFT HAND NEAR THUMB BEGINNING 3 DAYS AFTER VACCINATION AND STILL CONTINUING TO PRESENT (5 DAYS POST-VACCINATION). SHE ALSO REPORTS THAT HER LEFT THUMB ACHES. SHE ALSO REPORTS A BLACK AND BLUE, SORE  SPOT AT INJECTION SITE AND INTERMITTENT NAUSEA STILL CONTINUING 5 DAYS POST VACCINATION.
I developed a fixed skin eruption the evening of the day after my Moderna booster vacccination.  This consisted of separate areas of a flat erythematous macular rash on the right upper chest, between the breasts, beneath the breasts, a patch on the lateral aspect of the left breast, a patch around the right nipple,  a patch in each axilla, a patch around the umbilicus, a patch in the pubic area, a patch at the base of the posterior cervical region, a patch between the shoulder blades, a patch in the gluteal crease.  There was no pruritis or other symptoms related to the rash.    I developed what I consider to be expected symptoms the evening after my injection, consisting of chills, body aches, slight fever (100.9 F), and headache.  I had had similar symptoms after my second dose on 02/19/2021.  I took Tylenol for these symptoms.  I have had this fixed skin eruption in the past following previous episodes of fever/chills or after taking NSAIDS.  This current episode was much larger and more marked than I have had in the past.    I was scheduled to have an upper endoscopy at 12:30 pm on 11/12/2021.  However, the anesthesiologist was hesitant to perform the procedure because of the rash so I was rescheduled.  I did contact my primary care provider through patient app and she suggested filing the report.
This spontaneous report was received by a nurse, referring to a patient of an unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies was provided. On 02-OCT-2018, the patient was vaccinated with an improperly stored dose of VARIXAX injection, subcutaneously (lot number N010107, expiration date 28-MAR-2019) for prophylaxis. (Product storage error) (Poor quality product administered). No adverse effects were reported. The administered dose of vaccine experienced a temperature excursion of 2.5 degrees Celsius (-9°C to 8°C) for 18 hours 11 minutes. There was a previous temperature excursion of -9°C to 8°C for 3 hours 19 minutes. It was reported that sterile diluent administered concomitantly was properly stored. A data logger was involved. This is one of several reports received from the same reporter.
Initial report received from a health care professional in the USA on 28-September-2005. A 5 year old, male patient developed injection site bruising and swelling at the Daptacel injection site, within 24 hours after he received a fifth dose, intra-muscular injection in the left deltoid of Daptacel, lot number C2243Aa and a fourth dose, subcutaneous injection in the right arm of IPOL, lot number Y0324, on 24-September-2005. Within 24 hours, the "injection site appeared purple, swollen and redness spread to elbow as well as around the back of the shoulder. :Slight pain was reported and the patient's mother stated that he had a low grade fever on 25-September-2005. At the patient;s office visit on 27-September-2005, there was decreased swelling, no warmth but still pink." At the time of the report, the patient did no recover. Follow-up information received on 21/Nov/2005. The patient had no illness at the time of a vaccination. The physician reported the patient had an allergic reaction to the immunization. The Daptacel and IPOL were administered in the daytime on the 24/Sep/2005 and the reaction started that night. The patient was seen on the 27/Sep/2005 and was afebrile at the time. The rash was 15cm, lacy pink, blanches well. There was no warmth, only mild induration with front of arm. It was reported the patient recovered. As per physician the patient had a previous reaction on 06/Jan/2002 after receiving DPT lot #542A2 in the left arm on 30/May/2002 with erythema which spread to the axilla and chest. The patient was treated with Ancef. No further information is expected.
Pt came in for hepatitis B #2 vaccine. He states that he believes that the flu vaccine caused flu symptoms after shots 1/17/2012. He received flu vaccine, hep B & MMR vaccine 1/17/2012. Day after had aching in legs - 2 days later he had body aches, chills & head congestion. Symptoms lasted 2-3 days. He said he felt similar symptoms after last flu vaccine 3-4 years ago.
had slight pain in her arm; [her] heart was racing; [she] felt her heartbeat was faster; This is a spontaneous report from a Pfizer-sponsored program. A consumer reported for herself.  A 70-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 10Feb2021 as dose 1, single for COVID-19 immunisation. The patient's medical history included asthma, chronic obstructive pulmonary disease from an unknown date and unknown if ongoing for which patient takes steroid medications, heart rate increased from an unknown date and unknown if ongoing patient explained she does have this problem, heart raises easily with different things. On an unspecified date after receiving first dose of the Pfizer-BioNTech COVID-19 vaccine. Patient explained she had slight pain in her arm, heart was racing, and felt her heartbeat was faster. Patient described this experience as nothing out of control. Patient stated her second dose was scheduled on 03Mar2021. Patient explained she had appointment with her doctor in a few minutes. Patient also explained that she heard polyethylene glycol could be an allergens and doubts that her daughter's reaction was due to the mRNA. Patient was asking if her condition will inhibit the efficacy of the vaccine (Asthma, COPD), she took steroids as well after the first dose. The outcome of the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report was received from a physician regarding to a female patient of unknown age that had a prior positive history of tuberculosis on an unspecified date. No drug reactions or allergies were specified by the reporter. In October 2012 the patient was vaccinated with ZOSTAVAX (lot number and expiration date were not specified) (0.65mL, subcutaneous, no anatomical site reported). No other co-suspect medications or concomitant medications were reported. The physician reported that the patient experienced hot burning sensation on her chest as well as developed tiny bubbles on her chest on an unspecified date. The patient also complained of her whole body feeling itchy. The patient used a cold pack on an unspecified date to alleviate the hotness she felt on her chest. It was reported that the patient was no longer experiencing the hotness or bubbles on her chest. She continued to experience the overall itchiness. It was not specified if the patient sought medical attention. Additional information has been requested.
find out if his side effects are normal or if he maybe has a "blood clot."; the shoulder and neck on the side where he received his injection are swollen and painful; the shoulder and neck on the side where he received his injection are swollen and painful; the shoulder and neck on the side where he received his injection are swollen and painful; the shoulder and neck on the side where he received his injection are swollen and painful; across his collar bone is painful; my lips, nodes and top of my right my trap area is swollen; my lips, nodes and top of my right my trap area is swollen; I was told you might swollen on arm where shot went it or under your armpit not on top on my neck; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Apr2021 (lot number and expiry date not reported) as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 on an unspecified date for COVID-19 immunization. The patient stated that he received his second dose of the Pfizer COVID-19 vaccine on Saturday 17Apr2021. He stated that he called Pfizer yesterday, Sunday 18Apr2021 and reported his side effects, but was not able to have his questions answered. He was calling back to find out if his side effects were normal or if he maybe had a "blood clot." The patient stated that the shoulder and neck on the side where he received his injection were swollen and painful. The patient stated that across his collar bone was painful. He stated that the swelling and pain had improved slightly since yesterday. He stated that other than these side effects he feels great. He added, "I just got my second shot yesterday. No symptoms showed up except my lips nodes and top of my, right my trap area is swollen. So I want to make sure, is that normal? Because I was told you might swollen on arm where shot went it or under your armpit not on top on my neck." Clinical outcome of blood clot was unknown, while for the other events was recovering.  Information on the lot/batch number has been requested.
Patient states that the evening of the vaccine he started having tightness in his left arm and soreness as if he had worked out excessively.  As the evening went on the tightness spread across left arm into chest and neck and over to right arm.  Felt somewhat better in morning but still sore in both upper extremities.  2 days later (3rd day after shot) he went to use the restroom in his home and could not get himself off the toilet - he describes himself as having lost all strength in his legs and when he went to stand he fell right over.  He could not get up and had to be helped to the bedroom.  He rested for several hours and used a walker to ambulate around the house for the next several days.  Now feels back to normal.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Medium, Additional Details: Patient almost fainted after vaccine administration (2 minutes).  Called NP to him and NP had patient lie down for about 15 minutes.  Symptoms resolved after fluids, lifting legs above head and giving patient an ice pack.  BP measured at 5 minute increments until back to normal.  Patient waited an additional 15 minutes post incident to ensure that he felt back to normal.
This spontaneous report as received from a male patient of approximately 67 years old referring to himself with high blood pressure and sulfa-antibiotics allergy. On 31-OCT-2012, the patient was vaccinated with ZOSTAVAX, 0.65 ml/one dose, injection. Concomitant therapies included metoprolol and lisinopril. On an unknown date in May 2014 (also reported as week and a half ago), the patient developed shingles on the left side of his face. The shingles was in his mouth, ear, and everywhere else that is on the left side of the face. On an unknown date in May 2014 (also reported as same day he started to develop the shingles), the patient went to the hospital to seek medical attention and was admitted and he was not released until 20-MAY-2014. Patient was treated with unspecified intravenous (IV) antibiotics at the hospital. The patient stated that, pharmacy could be contacted to find the lot information for the ZOSTAVAX. The outcome of shingles on the left side of his face and the shingles is in his mouth, ear, and everywhere else that is on the left side of the face was reported as not recovered. Causality between ZOSTAVAX and the events were not reported. Additional information has been requested.
CHILLS; SLIGHT FEVER; HEADACHES; EXHAUSTION; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: UNKNOWN expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced chills, slight fever, headaches, and exhaustion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, slight fever, headaches, and exhaustion. This report was non-serious. This case, from the same reporter is linked to 20210435816 and 20210435816.
Information has been received from a physician concerning a 7 year old Hispanic male who on 15-FEB-2007, was vaccinated left anterior thigh with a second dose of varicella virus vaccine live (Oka/Merck) (lot number: 656122/1309F). There was no illness at the time of vaccination. On 16-FEB-2007 at 8:34 the patient developed a 3 inch round swollen erythematous area at site of injection. No lab diagnostics studies were performed. Unspecified medical attention was sought. The outcome was reported as recovered within a week. There were no adverse events following prior vaccination. There was no product quality complaint. Additional information has been requested.
Pt was given a non viable vaccine that was in an excursion the night prior. The excursion was not caught before this pt got vaccine.  The patients parent was called and rescheduled to come back in the office to repeat vaccine.